NCT00222573View on ClinicalTrials.gov

Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

46,000

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

February 28, 2005

Conditions
Acute Myocardial Infarction
Interventions
DRUG

clopidogrel and metoprolol

Trial Locations (2)

100037

Institute of Cadiovascular diseases, Fuwai hospital, Chinese academy of medical sciences, Beijing

OX3 7LF

Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford

Sponsors

Collaborators (2)

Sanofi
AstraZeneca
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

lead

University of Oxford

OTHER